Six Major Pharma Companies To Invest Rs 5,260 Crore In Telangana

Hyderabad:  Major pharmaceutical companies have promised investments to the tune of Rs 5,260 crore for setting up new units and expanding operations in the existing ones in Telangana.

Representatives of the pharma industries called on Chief Minister A. Revanth Reddy at the Secretariat on Friday afternoon and signed memoranda of understanding with the State Government in his presence. They assured to set up green industry without giving scope for pollution. The MoUs would help create 12,490 new jobs in the pharma sector and the State Government would provide land for the units in the proposed pharma city.

According to the MoUs, MSN Laboratories would set up a manufacturing facility as well as research and development centres and Laurus Labs and Aurobindo Pharma would set up formulation units while the Gland Pharma would set up an R&D centre as well as injectables and drug substance manufacturing unit. Dr. Reddy’s Labs on its part would set up injectables and biosimilar facility while Hetero Labs assured to set up plant for finished dosages and injectables.

The Chief Minister directed the officials concerned to take steps to allot lands for the pharma units to set up their units besides ensuring the necessary facilities for their operations.

Dr. Reddy’s Labs director Satish Reddy, Laurus Labs executive director V.V. Ravi Kumar, Gland Pharma chief executive officer Srinivas and Hetero Group managing director Vamsi Krishna were among others who called on the Chief Minister.

Related Posts

Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications

PIL in SC seeks time-bound probe, stringent action against fake drug networks

PIL in SC seeks time-bound probe, stringent action against fake drug networks

Ghaziabad: Fake supplement racket busted, 5 held

Ghaziabad: Fake supplement racket busted, 5 held

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records